HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Diisobutylaluminumhydride → (2-Methoxy-5-(2-methyl-2H-tetrazol-5-yl)phenyl)methanol

HRID 391404
Print

Reaction equation

HRID 391404 reaction equation
[CH3:1][O:2][C:3]1[CH:12]=[CH:11][C:10]([C:13]2[N:14]=[N:15][N:16]([CH3:18])[N:17]=2)=[CH:9][C:4]=1[C:5](OC)=[O:6].[H-].C([Al+]CC(C)C)C(C)C>C(Cl)Cl>[CH3:1][O:2][C:3]1[CH:12]=[CH:11][C:10]([C:13]2[N:14]=[N:15][N:16]([CH3:18])[N:17]=2)=[CH:9][C:4]=1[CH2:5][OH:6]
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

4

Reactant 2

HCID 21225700DiisobutylaluminumhydrideHCID 58993674Methyl 2-methoxy-5-(2-methyl-2H-tetrazol-5-yl)benzoate

Product 1

HCID 58993522(2-Methoxy-5-(2-methyl-2H-tetrazol-5-yl)phenyl)methanol

Reagents, catalysts & solvents 1

HCID 6344DichloromethaneSolvent

Conditions

Temperature
-78 °C

Procedure

Methyl 2-methoxy-5-(2-methyl-2H-tetrazol-5-yl)benzoate (130 mg, 0.52 mmol) was dissolved in methylene chloride (2 mL), cooled to −78° C. and treated with diisobutylaluminum hydride (1 M in methylene chloride, 1.5 mL, 1.5 mmol). After stirring at −78° C. for 1 h the reaction was quenched by a few drops of methanol (until no bubbling was observed) followed by addition of excess saturated sodium potassium tartarate (2 mL). The reaction was stirred at room temperature overnight, the layers were separated and the organic layer washed with brine (2×), dried over sodium sulfate and concentrated to afford 100 mg (86%). LC/MS (HPLC method 3): tR=1.68 min, 221.11 (MH)+

Workup

  1. customwas quenched by a few drops of methanol (until no bubbling
  2. additionfollowed by addition of excess saturated sodium potassium tartarate (2 mL)
  3. stirringThe reaction was stirred at room temperature overnight
  4. customthe layers were separated
  5. washthe organic layer washed with brine (2×)
  6. dry with materialdried over sodium sulfate
  7. concentrationconcentrated
  8. customto afford 100 mg (86%)

Sources & evidence

ORD record
ord-f2eeafa918fc4d93bd00faa567092491
Source dataset
uspto-grants-2013_02
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08383821B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes